{"entity":{"type":"insider","cik":"0001571320","url":"/insider/0001571320","json_url":"/insider/0001571320.json","name":"Regan Daniel Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":5,"first":"2014-03-07","last":"2015-02-03","span_basis":"filed_date"},"name_variants":[{"name":"Regan Daniel Paul","source":"filing","n_filings":5,"first_seen":"2014-03-07","last_seen":"2015-02-03"}],"transactions":[{"id":8449367,"accession":"0001144204-15-005703","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-15-005703","line_url":"/filing/0001144204-15-005703","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001571320","owner_name":"Regan Daniel Paul","owner_display_name":"Regan Daniel Paul","owner_url":"/insider/0001571320","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9847.0,"shares_display":"9,847","price_per_share":201.07274564842083,"price_display":"201.07","price_state":"stated","total_value":1979963.3264,"total_display":"1,979,963.33","total_whole":"1,979,963","shares_owned_after":4264.0,"shares_owned_after_display":"4,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-30","filed_date":"2015-02-03","scope":"insider","n_lines":5},{"id":8567796,"accession":"0001144204-15-001258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-001258","line_url":"/filing/0001144204-15-001258#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001571320","owner_name":"Regan Daniel Paul","owner_display_name":"Regan Daniel Paul","owner_url":"/insider/0001571320","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146.0,"shares_display":"146","price_per_share":176.4857,"price_display":"176.49","price_state":"stated","total_value":25766.9122,"total_display":"25,766.91","total_whole":"25,767","shares_owned_after":1264.0,"shares_owned_after_display":"1,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-05","filed_date":"2015-01-07","scope":"insider"},{"id":6475845,"accession":"0001144204-14-050902","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001144204-14-050902","line_url":"/filing/0001144204-14-050902","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001571320","owner_name":"Regan Daniel Paul","owner_display_name":"Regan Daniel Paul","owner_url":"/insider/0001571320","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8124.0,"shares_display":"8,124","price_per_share":325.6970552191039,"price_display":"325.70","price_state":"stated","total_value":2645962.8766,"total_display":"2,645,962.88","total_whole":"2,645,963","shares_owned_after":2134.0,"shares_owned_after_display":"2,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-15","scope":"insider","n_lines":25},{"id":6773651,"accession":"0001144204-14-042002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-042002","line_url":"/filing/0001144204-14-042002#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001571320","owner_name":"Regan Daniel Paul","owner_display_name":"Regan Daniel Paul","owner_url":"/insider/0001571320","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":250.0,"price_display":"250.00","price_state":"stated","total_value":250.0,"total_display":"250.00","total_whole":"250","shares_owned_after":1410.0,"shares_owned_after_display":"1,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-03","filed_date":"2014-07-08","scope":"insider"},{"id":6638185,"accession":"0001144204-14-014256","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001144204-14-014256","line_url":"/filing/0001144204-14-014256","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001571320","owner_name":"Regan Daniel Paul","owner_display_name":"Regan Daniel Paul","owner_url":"/insider/0001571320","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":434.691063765,"price_display":"434.69","price_state":"stated","total_value":8693821.2753,"total_display":"8,693,821.28","total_whole":"8,693,821","shares_owned_after":8849.0,"shares_owned_after_display":"8,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-05","filed_date":"2014-03-07","scope":"insider","n_lines":15}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS INC","url":"/issuer/0001270073","role":"Officer (Chief Commercial Officer)","n_filings":5,"first_seen":"2014-03-07","last_seen":"2015-02-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001571320","retrieved_at":"2026-08-26T15:37:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}